Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polyvalent design in the cGAS-STING pathway
Zachary T. Bennett, Suxin Li, Baran D. Sumer, et al.
Seminars in Immunology (2021) Vol. 56, pp. 101580-101580
Open Access | Times Cited: 13

Showing 13 citing articles:

Materials engineering strategies for cancer vaccine adjuvant development
Xuanbo Zhang, Bowei Yang, Qianqian Ni, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 9, pp. 2886-2910
Open Access | Times Cited: 60
Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
Kaiyuan Wang, Xuanbo Zhang, Hao Ye, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
The cGAS-STING pathway: a therapeutic target in diabetes and its complications
Wenjie He, Xingrui Mu, Xingqian Wu, et al.
Burns & Trauma (2024) Vol. 12
Open Access | Times Cited: 15
Phase Separation: The Robust Modulator of Innate Antiviral Signaling and SARS-CoV-2 Infection
Yi Zheng, Chengjiang Gao
Pathogens (2023) Vol. 12, Iss. 2, pp. 243-243
Open Access | Times Cited: 15
Recent advances in the activation and regulation of the cGAS-STING pathway
Run Fang, Qifei Jiang, Xiaoyu Yu, et al.
Advances in immunology (2022), pp. 55-102
Closed Access | Times Cited: 20
Aerosolized immunotherapeutic nanoparticle inhalation potentiates PD-L1 blockade for locally advanced lung cancer
Yang Liu, William Crowe, Lulu Wang, et al.
Nano Research (2022) Vol. 16, Iss. 4, pp. 5300-5310
Open Access | Times Cited: 18
Applications of cryo-EM in drug development for STING
Xiao‐chen Bai, Xuewu Zhang
Current Opinion in Structural Biology (2024) Vol. 84, pp. 102767-102767
Open Access | Times Cited: 3
Advances in the prerequisite and consequence of STING downstream signalosomes
Xinliang Lu, Xiaobing Li, Lili Li, et al.
Medical Review (2024) Vol. 4, Iss. 5, pp. 435-451
Open Access | Times Cited: 2
A non-lipid nucleic acid delivery vector with dendritic cell tropism and stimulation
Hyung Shik Kim, Elias A. Halabi, Noah Enbergs, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2934-2945
Open Access | Times Cited: 2
Functionalized Polymeric Micelles for Targeted Cancer Therapy: Steps from Conceptualization to Clinical Trials
A.S. Serras, Célia Faustino, Lídia Pinheiro
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1047-1047
Open Access | Times Cited: 2
Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies
Gemalene Sunga, Jeffrey D. Hartgerink, Andrew G. Sikora, et al.
Tissue Engineering Part C Methods (2023) Vol. 29, Iss. 6, pp. 257-275
Open Access | Times Cited: 2
Engineering the physical characteristics of biomaterials for innate immune-mediated cancer immunotherapy
E K Kim, Katharina Wahl, Erica Guelfi, et al.
Journal of Controlled Release (2024) Vol. 378, pp. 814-830
Closed Access
1155 ONM-501, a polyvalent STING agonist, exhibits anti-tumor efficacy with increased tumor T-cell infiltration in mice and is well tolerated in rats and non-human primates
Zirong Chen, Jason Miller, Wei Li, et al.
Regular and Young Investigator Award Abstracts (2022), pp. A1198-A1198
Open Access | Times Cited: 1
Page 1

Scroll to top